Novo’s Wegovy Approved After Superior Weight-Loss Impact Shown

Novo Nordisk A/S gained U.S. approval for its therapy that helped patients lose about 15% of their body weight on average in trials, an alternative to an existing treatment from the Danish drugmaker as well as invasive, costly obesity surgery.

Read more

Contact Us

Thank you for getting in touch!​
One of our colleagues will get back in touch with you soon!